Mukka Proteins profit and loss

Latest FY26

Revenue: ₹1,449cr+44.0% on FY25
EBITDA: ₹115cr+20.8% on FY25
Net profit: ₹57.1cr+18.7% on FY25
EPS: ₹1.74+12.3% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Expenses
	1,768	1,449	1,006	1,380
	27.7	28.7	15.1	19.4
	1,796	1,478	1,022	1,399
	1,630	1,431	916	1,327
	−208	−261	−141	−191
	49.2	40.8	32.3	29.3
	59.0	53.6	37.3	25.1
	18.1	16.6	13.6	12.3
	149	125	105	110
	1,697	1,405	962	1,312
	148	115	94.9	105
	130	98.0	81.3	93.1
Profit
	98.6	73.1	59.2	87.5
	98.6	73.1	59.2	87.5
	18.0	19.8	12.2	14.6
	8.0	−1.8	0.0	−1.5
	26.0	18.1	12.2	13.2
	1.6	2.1	1.1	0.0
	74.1	57.1	48.1	74.3
	72.6	55.0	47.0	74.3
	0.5	−0.6	−0.3	−0.3
	74.6	56.5	47.8	74.0
	69.1	52.1	46.5	70.1
	5.0	5.0	1.6	4.3
Per share
	₹2.31	₹1.74	₹1.55	₹3.10
	₹2.31	₹1.74	₹1.55	₹3.10
Revenue detail — as filed
	—	0.0	1.1	−6.7
Other comprehensive income — detail
	0.5	−0.6	−0.3	—
	1.0	0.5	0.0	−0.1
	−0.6	−1.1	−0.4	−0.2
	69.8	51.9	46.3	69.8
	4.8	4.6	1.5	4.2
Per share — as-filed variants
	₹2.31	₹1.74	₹1.55	₹3.10
	₹2.31	₹1.74	₹1.55	₹3.10
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	346	280	232	244
	19.6%	19.3%	23.0%	17.7%
Adjusted (ex-exceptional items) — derived
	98.6	73.1	59.2	87.5
	74.1	57.1	48.1	74.3
	₹2.31	₹1.74	₹1.55	₹3.10

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MUKKA₹24.68

Mukka Proteins Limited

· FMCG & Retail

Annual Quarterly₹ CrorePeersNARMADA KSEMcap ₹740 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	1,379.8	1,006.4	1,449.5	1,768.3
Other Income	19.4	15.1	28.7	27.7
Total Income	1,399.3	1,021.5	1,478.1	1,796.1
Expenses
+ Cost of Materials Consumed	1,326.9	916.1	1,430.7	1,629.9
+ Changes in Inventories	-191.4	-141.4	-261.4	-208.0
+ Employee Benefit Expense	29.3	32.3	40.8	49.2
+ Finance Costs	25.1	37.3	53.6	59.0
+ Depreciation & Amortisation	12.3	13.6	16.6	18.1
+ Other Expenses	109.5	104.6	124.8	149.2
Total Expenses	1,311.8	962.3	1,405.1	1,697.5
EBITDA	105.5	94.9	114.6	148.0
EBIT	93.1	81.3	98.0	129.9
Profit
PBT before Exceptional Items	87.5	59.2	73.1	98.6
Pretax Income	87.5	59.2	73.1	98.6
+ Current Tax	14.6	12.2	19.8	18.0
+ Deferred Tax	-1.5	0.0	-1.8	8.0
Tax Expense	13.2	12.2	18.1	26.0
+ Share of Associates & JVs	0.0	1.1	2.1	1.6
Net Income	74.3	48.1	57.1	74.1
+ Net Income — Continuing Ops	74.3	47.0	55.0	72.6
+ Other Comprehensive Income	-0.3	-0.3	-0.6	0.5
Total Comprehensive Income	74.0	47.8	56.5	74.6
Net Income to Common	70.1	46.5	52.1	69.1
Minority Interest	4.3	1.6	5.0	5.0
Per Share
Basic EPS	3.10	1.55	1.74	2.31
Diluted EPS	3.10	1.55	1.74	2.31
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs	-6.7	1.1	0.0	—
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	-0.3	-0.6	0.5
+ Items NOT to be Reclassified to P&L	-0.1	0.0	0.5	1.0
+ Items to be Reclassified to P&L	-0.2	-0.4	-1.1	-0.6
Comprehensive Income — Owners of Parent	69.8	46.3	51.9	69.8
Comprehensive Income — Non-controlling Interests	4.2	1.5	4.6	4.8
Per Share — as-filed variants
Basic EPS — Continuing Operations	3.10	1.55	1.74	2.31
Diluted EPS — Continuing Operations	3.10	1.55	1.74	2.31
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	244.3	231.7	280.1	346.5
Gross Margin %	17.71	23.03	19.33	19.59
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	87.5	59.2	73.1	98.6
Net Income Adj (tax-effected)	74.3	48.1	57.1	74.1
EPS Adj	3.10	1.55	1.74	2.31
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	—	—	1.00	1.00
Paid Up Equity Capital	30.0	30.0	30.0	30.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.